- John Creecy, Chief Executive Officer
Mr. Creecy is Chief Executive Officer and a Director of Remeditex Ventures after serving as President and Chief Executive Officer of Hunt Petroleum Corporation. Prior to that, Mr. Creecy served as Chief Operating Officer of Hodges Company, Inc. Mr. Creecy is a Graduate of Texas Tech University with a Bachelor's Degree in Accounting and holds a Master of Science Degree in Tax from North Texas State University (Now the University of North Texas). Mr. Creecy is a member of both the Dallas Assembly and the Dallas Citizens Council, civic organizations comprised of business leaders in Dallas.
- Brett Ringle, President
Mr. Ringle is President and a Director of Remeditex Ventures and most recently was with Hunt Petroleum as Vice President and Director. Prior to that, he was a partner at the law firm Jones Day. He graduated from the University of Texas at Austin with BA and holds a JD from the University of Texas Law School.
- Barry Burgdorf, Chief Operating Officer
Mr. Burgdorf is Chief Operating Officer of Remeditex Ventures. He joins Remeditex after a serving as the Chief Operating Officer and General Counsel of VuCOMP, Inc. while also maintaining a corporate legal practice as a shareholder at the law firm of Beatty, Bangle and Strama. Prior to that, he was the Vice Chancellor and General Counsel of The University of Texas System (2005-2013), a partner at the law firm of Vinson & Elkins (1998-2005), General Counsel of Samsung Austin Semiconductor (1996-1998) and an associate at Vinson & Elkins (1990-1996). Mr. Burgdorf graduated from The University of Texas with a BBA in Finance and International Business, Southern Methodist University with an MBA and The University of Texas with a J.D. He is currently vice chairman of the Board of Regents for Concordia University – Texas, a member of the Board of Directors for The American Heart Association – Austin Chapter, and a member of the American Law Institute. He is a recipient of the Magna Stella Award of The General Counsel Forum for outstanding leadership and management (2011) and Nightingale’s Healthcare Outstanding General Counsel (2006).
- Dennis Stone, MD, Chief Scientific Officer
Dr. Stone is Chief Scientific Officer and a Director of Remeditex Ventures. He joined Remeditex from UT Southwestern Medical Center (UTSW) where he was Professor of Internal Medicine, Physiology, and Biochemistry. He served as the Vice President of Technology Development since 1998. In that role, he directed licensing operations as well as the biotechnology development initiative taking place at UTSW and was the liaison with pharmaceutical and biotechnology companies interested in partnership with UTSW scientists. During his tenure, Dr. Stone and his team created over $100M in and launched six start-up biotechnology companies that collectively have raised over $500 million in financing. Dr. Stone has participated on the board of directors of Eliance Biotechnology, Inc., Myogen, Inc., miRagen Therapeutics, Inc., MacroGenics, Inc., and Reata Pharmaceuticals, Inc. In addition, he served as the chairman of the U.T. Regents' Technology Transfer Commission and was vice chairman of the board of the Texas Emerging Technology Fund's Life Science Commercialization Center. Dr. Stone received his undergraduate training in the Plan II Program at The University of Texas at Austin and his medical degree from UTSW.
- Claire Aldridge, PhD, Vice President, Venture Development
Dr. Aldridge is Vice President, Venture Development for Remeditex Ventures. She came to Remeditex from UTSW where she held numerous positions, most recently as Director, Commercialization Relations in the Office for Technology Development. This office was responsible for the commercialization of scientific discoveries made by the clinical and research faculty. Dr. Aldridge received her BS degree in Biomedical Science from Texas A&M University and her PhD in Immunology and Genetics from Duke University.
- John Elwood, Vice President, Business Development
Mr. Elwood is Vice President, Business Development for Remeditex Ventures after serving as Associate Director UTSW in the Office for Technology Development. There he managed academic projects with commercial potential and helped form companies. He was instrumental in forming and operating UT Southwestern's biomedical incubator called Pipeline at BioCenter. Prior to UTSW, John held a variety of operational and business development positions at Cumbre Pharmaceuticals in Dallas and Sugen and Tularik Inc. in South San Francisco. He also served as a consultant for companies in North Carolina's Research Triangle and Triad areas. He has a BA in Biology from the University of Virginia and a MBA from the University of San Francisco.
- Peggy Oglesby Allison
Peggy Allison has been a civic leader in Dallas for many years. After receiving her Bachelor€s degree in Philosophy from Smith College, she continued her studies earning a Master€s in Mathematics from Southern Methodist University and completing graduate work in Number Theory at Cambridge University in England. In addition to careers in investment management, she has also provided her exceptional leadership and enthusiasm to community endeavors including the Dallas Junior League, The Science Place, Child Care Dallas, and the Museum of Science and Nature.
- Colleen McHugh, JD
Colleen McHugh is a highly regarded Texas lawyer with a distinguished record of public and professional service. She was the first woman Chairman of The University of Texas System Board of Regents and of the Texas Public Safety Commission. As Vice Chairman of the Board of Regents, Ms. McHugh chaired the Health Affairs Committee. She served as the Board of Regents Athletics Liaison and on the Board of Directors of The University of Texas Investment Management Company (UTIMCO). The Texas Department of Public Safety's diverse divisions include the Texas Highway Patrol and the Texas Rangers.
The lawyers of Texas elected Ms. McHugh State Bar of Texas President for the bar's 1996-1997 term. As President, Ms. McHugh led the successful legislative effort to increase legal services funding for disadvantaged Texans. She was the first woman to chair the State Bar of Texas Board of Directors.
A strategic advisor and goal oriented lawyer, Ms McHugh is recognized for her innovative and pragmatic approach to managing complex issues. Business leaders rely on her good judgment, communication skills, and problem-solving ability. She is employed as Vice President, Compliance, Risk Management and Privacy Officer for CHRISTUS Spohn Health System.
Ms. McHugh is board certified in Labor and Employment Law by the Texas Board of Legal Specialization and is a member of the highly regarded American Law Institute, the organization responsible for publishing the Restatement of Law series. Ms. McHugh is a member of the American Bank, N.A. Board of Directors.
Ms. McHugh received her undergraduate degree from Southern Methodist University and her law degree from St. Mary's University School of Law.
- Clay M. Hunt
Clay M. Hunt is co-founder and owner of Atropos Exploration Company, an independent oil and gas exploration company focusing most operations in the West Texas natural gas fields.
Prior and in addition to establishing Atropos Exploration, Clay is also co-founder and owner of Texana Resources Corporation, Atropos Production Corporation, Indefatigable Corporation, McLean Investment, Hotspur, LP, and Irion County Properties. Clay focuses his energy in drilling and production as well as gas contract services.
Clay served as a director on the boards of Dallas Bancshares and Compass Bank North Texas. He is currently on the Board of Coastal Cookie Company and Park Cities Bank. He is a past president of the Dallas Petroleum Club. Clay served on the District Leadership Council for Highland Park Independent School District and Highland Park Sports Club.
Clay earned a BBA degree from the University of Texas at Austin in 1972.